AVITA Medical, Inc. (RCEL)
9.92
-0.14
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
9.92
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical Total Liabilities (Quarterly) : 75.62M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.62M |
| March 31, 2026 | 74.71M |
| December 31, 2025 | 69.34M |
| September 30, 2025 | 66.31M |
| June 30, 2025 | 67.18M |
| March 31, 2025 | 70.40M |
| December 31, 2024 | 72.00M |
| September 30, 2024 | 65.86M |
| June 30, 2024 | 60.36M |
| March 31, 2024 | 60.07M |
| December 31, 2023 | 58.23M |
| September 30, 2023 | 14.05M |
| Date | Value |
|---|---|
| June 30, 2023 | 15.23M |
| March 31, 2023 | 13.10M |
| December 31, 2022 | 11.70M |
| September 30, 2022 | 10.66M |
| June 30, 2022 | 9.946M |
| March 31, 2022 | 8.676M |
| June 30, 2021 | 9.846M |
| March 31, 2021 | 9.144M |
| December 31, 2020 | 9.708M |
| September 30, 2020 | 9.931M |
| June 30, 2020 | 10.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.434B |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.78M |
| Shareholders Equity (Quarterly) | -27.84M |
| Debt to Equity Ratio | -1.742 |
| Current Ratio | 0.4132 |
| Net Debt Paydown Yield | -0.69% |